A Study to Describe the Effectiveness and Safety of Venetoclax Treatment in Chronic Lymphocytic Leukemia (CLL) Patients in Routine Clinical Practice
Clinical trial NCT03659669 · SUSPENDED
Trial details
- NCT number
- NCT03659669
- Sponsor
- AbbVie
- Status
- SUSPENDED
- Study type
- OBSERVATIONAL
- Start date
- 2019-02-10
- Primary completion
- 2027-02-28
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.